Back to top
more

Masimo (MASI)

(Delayed Data from NSDQ)

$124.50 USD

124.50
1,191,499

-1.67 (-1.32%)

Updated May 31, 2024 04:00 PM ET

After-Market: $124.48 -0.02 (-0.02%) 7:58 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy24.08%
2Buy17.91%
3Hold9.44%
4Sell5.10%
5Strong Sell2.55%
S&P50011.04%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

2-Buy of 5   2      

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

Value Score A
Growth Score A
Momentum Score A
VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

C Value C Growth B Momentum B VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Bottom 40% (149 out of 250)

Industry: Medical - Instruments

Better trading starts here.

Zacks News

Here's Why Investors Should Buy Masimo (MASI) Right Now

Masimo (MASI) announced 510(k) clearance and full-market release of its proprietary Rad-97 Pulse CO-Oximeter earlier this month.

    The Zacks Analyst Blog Highlights: Cardinal Health, Penumbra, STAAR Surgical, Masimo and Smith & Nephew

    The Zacks Analyst Blog Highlights: Cardinal Health, Penumbra, STAAR Surgical, Masimo and Smith & Nephew

      Top MedTech Stocks Safe from Graham-Cassidy Repeal Bill

      The investment climate for medical device majors has become increasingly volatile due to political potshots in Capitol Hill, for and against Obamacare.

        Republicans Take Last Shot at Obamacare: 5 MedTech Stocks to Buy

        The fate of Obamacare will be decided on Sep. 30. No matter what the future holds, the day will provide investors a clear picture of where the MedTech industry is headed.

          Masimo (MASI) Launches Rad-97 CO-Oximeter Post FDA Clearance

          Masimo's (MASI) newly-launched Rad-97 Pulse CO-Oximeter will strengthen the company's presence in the Advanced Monitoring Technologies space.

            5 Discounted MedTech Stocks for a Healthy Portfolio

            In view of the current political scenario and banking on favorable metrics, these five MedTech stocks stand out as the most suitable value picks.

              Why Is Masimo (MASI) Down 1.5% Since the Last Earnings Report?

              Masimo (MASI) reported earnings about a month ago. What's next for the stock? We take a look at earnings estimates for some clues.

                Ride Out MedTech Volatility With These 3 Ultra-Safe Stocks

                In view of the current political scenario and banking on favorable metrics, these three low-beta MedTech stocks stand out as the most suitable value picks.

                  3 Excellent Value Picks as Political Chaos Grips MedTech

                  In view of the current political scenario and banking on favorable metrics, these three MedTech stocks stand out as the most suitable value picks.

                    Zacks.com featured highlights: CBRE Group, East West Bancorp, Hasbro, Canadian Pacific Railway and Masimo

                    Zacks.com featured highlights: CBRE Group, East West Bancorp, Hasbro, Canadian Pacific Railway and Masimo

                      5 GARP Stocks to Buy for Marvelous Returns

                      GARP helps an investor gain exposure to stocks that are undervalued and have impressive prospects.

                        Here's Why Chemed (CHE) is a Suitable Growth Pick for Now

                        Banking on favorable Net Margin and ROE, Chemed (CHE) stands out as one of the most suitable growth stocks.

                          IDEXX Laboratories (IDXX), Great Growth Pick: Here's Why

                          Banking on a number of favorable metrics, IDEXX Laboratories (IDXX) stands out as one of the most suitable growth stock.

                            Is Amedisys (AMED) a Great Value Stock for Your Portfolio?

                            Banking on a number of favorable metrics, Amedisys (AMED) stands out as one of the most suitable value stock.

                              Here's Why Masimo (MASI) is a Suitable Value Pick for Now

                              Masimo (MASI) seems to be a solid value pick with favorable P/E ratio and P/FCF ratio compared with its broader industry.

                                McKesson Banks on Distribution Business Amid Pricing Woes

                                McKesson (MCK) entered fiscal 2018 with an assumption of branded inflation in the mid-single digits. Pricing pressure in the independent retail pharmacy channel is a headwind.

                                  BioTelemetry Hits a 52-Week High: What's Driving the Stock?

                                  BioTelemetry (BEAT) is putting efforts in product innovation through research and development. The company recently announced the acquisition of LifeWatch AG in a deal valued at about $280 million.

                                    Masimo (MASI) Introduces SafetyNet System in Dubai Hospitals

                                    Masimo's (MASI) proprietary Patient SafetyNet system's introduction in the Dubai market is in line with its strategy of becoming the dominant player in the pulse oximetry market.

                                      Zacks.com featured highlights: CBRE Group, Canadian Pacific Railway, East West Bancorp, Hasbro and Masimo

                                      Zacks.com featured highlights: CBRE Group, Canadian Pacific Railway, East West Bancorp, Hasbro and Masimo

                                        Top 5 GARP Stocks to Scoop Up Right Now

                                        The GARP approach prefers stocks that are priced below the market or any reasonable target determined by fundamental analysis.

                                          Masimo (MASI) Beats on Q2 Earnings and Revenues, Guides Up

                                          Masimo's (MASI) stable performance across its businesses was the key highlight of second quarter.

                                            MedTech Stock Earnings Slated for Aug 2: CAH, HOLX & More

                                            Despite solid strategic initiatives, the ongoing political conundrum at the Capitol Hill is likely to affect earnings results of these four major Medical Technology bigwigs.

                                              Masimo (MASI) Rainbow Super DCI-mini Sensor Now CE Marked

                                              Irvine, CA-based Masimo Corporation (MASI) recently announced the receipt of CE mark for the noninvasive and reusable rainbow Super DCI-mini sensor.

                                                Masimo (MASI) Presents Utility Study of Oxygen Reserve Index

                                                Masimo Corporation (MASI) recently announced data from its study evaluating the potential clinical utility of Masimo Oxygen Reserve Index.

                                                  Zacks.com featured highlights: 58.com, RPC, U.S. Silica Holdings, Masimo and Manitowoc

                                                  Zacks.com featured highlights: 58.com, RPC, U.S. Silica Holdings, Masimo and Manitowoc